Esperion Therapeutics (NASDAQ: ESPR) Stock Jumps on Upbeat Q1 Financial Report
Esperion Therapeutics (NASDAQ: ESPR) stock surged about 12% in intraday trading Tuesday after the company reported better-than-expected Q1 financial results. […]
Esperion Therapeutics (NASDAQ: ESPR) Stock Jumps on Upbeat Q1 Financial Report Read More »